◂ Announcements

Dec 19, 2018ACQUISITIONUnited States

Alcon acquires Tear Film Innovations for dry eye device

Alcon, a division of Novartis, has acquired Tear Film Innovations, Inc., manufacturer of the iLux Device for treating Meibomian Gland Dysfunction. The deal expands Alcon's dry eye portfolio.

Status

Completed

ProductsiLux Device for dry eye treatment

CompaniesAlcon Group acquirer Tear Film Innovations, Inc. target

Sectors#Medical Devices

“With the acquisition of Tear Film, we're excited to bring this latest innovation to treat the millions of people around the world who suffer from dry eye.”novartis.com

1 source
novartis.comAlcon Announces Acquisition of Tear Film Innovations, Inc. | NovartisDec 19, 2018

Summarized from public sources; check the original articles before acting on it.

More from Alcon Group

profile ▸

Sep 12, 2019EXPANSIONZelenograd, Moscow region, Russia$4.20Mops 12 Sep 2019
Alcon localizes IOL production at Nanoptika plant in Russia
Alcon Group Nanoptika partner imeda.ru
Nov 9, 2017EXPANSIONJohns Creek, Georgia, United States$97.0M100 jobs
Alcon announces $97M expansion in Johns Creek, Georgia
Alcon Group appenmedia.com
Feb 3, 2017ACQUISITIONUnited Kingdom
Alcon Group acquires GE Precision Engineering Ltd
Alcon Group acquirer GE Precision Engineering Ltd target alcon-precision.co.uk

Loading…

Alcon acquires Tear Film Innovations for dry eye device · Endata